R. Jódar

463 total citations
12 papers, 207 citations indexed

About

R. Jódar is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, R. Jódar has authored 12 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in R. Jódar's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pneumonia and Respiratory Infections (2 papers) and Antibiotic Resistance in Bacteria (2 papers). R. Jódar is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Pneumonia and Respiratory Infections (2 papers) and Antibiotic Resistance in Bacteria (2 papers). R. Jódar collaborates with scholars based in Spain. R. Jódar's co-authors include J. M. Llop Talaverón, David Berlana, M. Badia, Frederic Manresa, Ariadna Padullés, Leandre Farràn, Antonio Vidaller, Alícia Domingo, José Bruno Montoro Ronsano and Joan‐Ramon Laporte and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Nutrition and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

R. Jódar

12 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Jódar Spain 6 106 82 68 56 43 12 207
M. Badia Spain 8 102 1.0× 81 1.0× 62 0.9× 48 0.9× 48 1.1× 14 362
Seung-Kwan Lim South Korea 11 87 0.8× 184 2.2× 37 0.5× 63 1.1× 11 0.3× 18 333
V. Pascual Spain 6 53 0.5× 160 2.0× 22 0.3× 57 1.0× 45 1.0× 7 269
Sami Abdellatif Tunisia 6 110 1.0× 81 1.0× 70 1.0× 39 0.7× 64 1.5× 14 181
C Koch Denmark 6 114 1.1× 53 0.6× 57 0.8× 208 3.7× 22 0.5× 18 317
Hélène Poupet France 7 48 0.5× 77 0.9× 17 0.3× 42 0.8× 110 2.6× 16 244
Salah Ben Lakhal Tunisia 7 105 1.0× 102 1.2× 71 1.0× 40 0.7× 65 1.5× 21 203
Ahlem Trifi Tunisia 5 99 0.9× 84 1.0× 69 1.0× 38 0.7× 66 1.5× 17 174
E. Williams Australia 8 101 1.0× 76 0.9× 76 1.1× 239 4.3× 14 0.3× 22 375
Leila Hergafi Tunisia 6 201 1.9× 126 1.5× 153 2.3× 24 0.4× 38 0.9× 8 362

Countries citing papers authored by R. Jódar

Since Specialization
Citations

This map shows the geographic impact of R. Jódar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Jódar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Jódar more than expected).

Fields of papers citing papers by R. Jódar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Jódar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Jódar. The network helps show where R. Jódar may publish in the future.

Co-authorship network of co-authors of R. Jódar

This figure shows the co-authorship network connecting the top 25 collaborators of R. Jódar. A scholar is included among the top collaborators of R. Jódar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Jódar. R. Jódar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zozaya, Néboa, Teresa Caballero, Teresa Gonzalez‐Quevedo, et al.. (2022). A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain. SHILAP Revista de lepidopterología. 9. 14–21. 2 indexed citations
2.
Padullés, Ariadna, et al.. (2018). Management of Tizanidine Withdrawal Syndrome: A Case Report. Clinical Medicine Insights Case Reports. 11. 3570388358–3570388358. 8 indexed citations
4.
Talaverón, J. M. Llop, et al.. (2012). Soporte nutricional y factores de riesgo de aparición de fístulas enterocutáneas. Nutrición Hospitalaria. 27(1). 213–218. 5 indexed citations
5.
Badosa, E. Leiva, M. Pineda, Ariadna Padullés, et al.. (2012). Safety of expanded therapeutic range of valproic acid. European Journal of Hospital Pharmacy. 19(2). 196.2–197. 1 indexed citations
6.
Talaverón, J. M. Llop, et al.. (2012). [Nutritional support and risk factors of appearance of enterocutaneous fistulas].. PubMed. 27(1). 213–8. 7 indexed citations
7.
Berlana, David, J. M. Llop Talaverón, Frederic Manresa, & R. Jódar. (2011). Outpatient Treatment of Pseudomonas aeruginosa Bronchial Colonization with Long‐term Inhaled Colistin, Tobramycin, or Both in Adults without Cystic Fibrosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(2). 146–157. 25 indexed citations
8.
9.
Berlana, David, et al.. (2005). Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. American Journal of Health-System Pharmacy. 62(1). 39–47. 132 indexed citations
10.
Talaverón, J. M. Llop, et al.. (2001). Colonization and bacteremia risk factors in parenteral nutrition catheterization. Clinical Nutrition. 20(6). 527–534. 18 indexed citations
11.
Jódar, R., et al.. (2000). Los servicios farmacéuticos desde la perspectiva asistencial. Análisi de situación y líneas estratégicas. 2(4). 223–258. 2 indexed citations
12.
Rodríguez, C.A., Josep Arnau, R. Jódar, et al.. (1989). Evaluation of Cefonicid Use in a General Hospital. DICP. 23(2). 154–156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026